[Results of clinical experiments with a new antifibrinolytic agent para-amino-methylbenzoic acid (PAMBA)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D062365:Aminobenzoates; D000933:Antifibrinolytic Agents
Wyniki doświadczeń klinicznych z nowym środkiem przeciwfibrynolitycznym--kwasem para-amino-metylobenzoesowym (PAMBA)